Victory-Vault
Merck snaps up Chinese obesity drug in nearly $2 billion deal
admin
December 19, 2024
Business


Merck will receive an exclusive global license to Chinese drugmaker Hansoh's HS-10535, an experimental oral drug that targets GLP-1 receptors. Read more
Share on Facebook
Share on Twitter

Leave a Reply

Your email address will not be published. Required fields are marked *